PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Infectious Diseases, Department of Medicine, McGill University, Montréal, Canada; Clinical Practice Assessment Unit, Department of Medicine, McGill University, Montréal, Canada; Department of Epidemiology, Occupational Health, and Biostatistics, McGill University, Montréal, Canada. Electronic address: todd.lee@mcgill.ca.\', \'Clinical Practice Assessment Unit, Department of Medicine, McGill University, Montréal, Canada; Division of General Internal Medicine, Department of Medicine, McGill University, Montréal, Canada.\', \'Department of Epidemiology, Occupational Health, and Biostatistics, McGill University, Montréal, Canada.\', \'Division of Infectious Diseases, Department of Medicine, McGill University, Montréal, Canada.\', \'Department of Epidemiology, Occupational Health, and Biostatistics, McGill University, Montréal, Canada; Division of Cardiology, Department of Medicine, McGill University, Montréal, Canada.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S1201-9712(21)00077-110.1016/j.ijid.2021.01.065
?:hasPublicationType
?:journal
  • International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
is ?:pmid of
?:pmid
?:pmid
  • 33540128
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Remdesivir and systemic corticosteroids for the treatment of COVID-19: A Bayesian re-analysis.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all